BioMarin Pharmaceutical Inc.
Industry / private company
Location:
San Rafael,
United States (USA) (US)
ISNI: 0000000405075335
ROR: https://ror.org/03fmvqd28
Show on Map:
Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability (2025)
Sabeh P, Dumas SA, Maios C, Daghar H, Korzeniowski M, Rousseau J, Lines M, et al.
Journal article
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients (2016)
Hein A, Gaß P, Walter CB, Taran FA, Hartkopf A, Overkamp F, Kolberg HC, et al.
Journal article